MyFinsight
Home
About
Contact
vktx: the income statement
Download
Download image
Comprehensive loss
-$90,247,000
(-329.01%↓ Y/Y)
Unrealized gain on
securities
$540,000
(-86.16%↓ Y/Y)
Realized gain on
investments, net
$10,000
(-90.83%↓ Y/Y)
Interest income, net
$7,772,000
(-32.60%↓ Y/Y)
Net loss
-$90,787,000
(-264.02%↓ Y/Y)
Total other income,
net
$7,774,000
(-33.08%↓ Y/Y)
Amortization of financing
costs
$8,000
(-66.67%↓ Y/Y)
Loss from operations
-$98,561,000
(-169.62%↓ Y/Y)
Total operating
expenses
$98,561,000
(169.62%↑ Y/Y)
General and
administrative
$8,608,000
(-37.49%↓ Y/Y)
Research and development
$89,953,000
(294.79%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)
viking_9_15_logo-svg
Viking Therapeutics, Inc. (VKTX)